Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2025)
Rocket Pharmaceuticals' (RCKT) quarterly Other Operating Expenses came in at $271000.0 in Q2 2025, up 27200.0% quarter-over-quarter from -$1000.0 in Q4 2020.
Rocket Pharmaceuticals (RCKT) Other Operating Expenses (2017 - 2025) Analysis & Trends
Rocket Pharmaceuticals has disclosed Other Operating Expenses across 4 years of filings, most recently posting $271000.0 for Q2 2025.
- Other Operating Expenses for Q2 2025 came in at $271000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $271000.0 (changed N/A YoY), and the FY2018 annual result was -$78.2 million, down 118.81% from the prior year.
- Other Operating Expenses came in at $271000.0 for Q2 2025 at Rocket Pharmaceuticals, up from -$1000.0 in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $271000.0 in Q2 2025 to a low of $271000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - |
| 10 | Rocket Pharmaceuticals | 296.03 Mn | 296.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 271,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2018 | -78.22 Mn |
| Sep 30, 2018 | -39,000.00 |
| Jun 30, 2018 | -5,000.00 |
| Mar 31, 2018 | -16.00 Mn |
| Dec 31, 2017 | -35.76 Mn |
| Mar 31, 2017 | -15.67 Mn |